News Focus
News Focus
icon url

oldberkeley

01/10/13 5:24 PM

#155210 RE: exwannabe #155209

Somehow I can already smell the failure in this trial.

One need only cite CynicalTrader's posting of this article from a few days ago:

Tufts: Billions wasted in pharma R&D despite new biz models

http://www.fiercebiotech.com/story/tufts-billions-wasted-pharma-rd-despite-new-biz-models/2013-01-08

icon url

iwfal

01/10/13 6:12 PM

#155211 RE: exwannabe #155209

By the time enrollment is getting up to speed, patients are going to want to be on such and not willing to enroll in CTIC's trial. With enrollment drying up, they just call an early halt (possibly timed after seeing data).



You couldn't possibly be suggesting that some biotechs actually try to run trials that will dragggggg oooouuuuutttt without actually inconveniently failing or succeeding?